Lataa...
Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis
This article will review current treatment options for multiple sclerosis (MS) while keeping our primary focus on alemtuzumab, as it is now approved in more than 65 countries. From a pathophysiological point of view, MS is a disabling disease impacting a patient's life both physically and menta...
Tallennettuna:
| Julkaisussa: | Cureus |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cureus
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7948316/ https://ncbi.nlm.nih.gov/pubmed/33728194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13246 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|